Average Co-Inventor Count = 5.14
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (12 from 444 patents)
2. Novartis Ag (5 from 3,923 patents)
3. Axolabs Gmbh (5 from 7 patents)
4. Arrowhead Pharmaceuticals, Inc. (4 from 96 patents)
5. Arrowhead Research Corporation (1 from 18 patents)
6. Alnylam Europe Ag (1 from 3 patents)
28 patents:
1. 11208662 - RNAi inhibition of alpha-ENaC expression
2. 10544418 - RNAi inhibition of alpha-ENaC expression
3. 9914927 - RNAi inhibition of alpha-ENaC expression
4. 9636302 - Lipids and compositions for intracellular delivery of biologically active compounds
5. 9506067 - Compositions and methods for inhibiting expression of the HAMP gene
6. 9476052 - RNAi inhibition of alpha-ENaC expression
7. 9433681 - Lipids and compositions for intracellular delivery of biologically active compounds
8. 9278130 - Lipids and compositions for intracellular delivery of biologically active compounds
9. 9149531 - Lipids and compositions for intracellular delivery of biologically active compounds
10. 9090895 - Compositions and methods for inhibiting expression of the HAMP gene
11. 9074212 - RNAi inhibition of alpha-ENaC expression
12. 9057069 - Compositions and methods for inhibiting expression of Eg5 gene
13. 8791250 - Compositions and methods for inhibiting expression of the HAMP gene
14. 8691750 - Lipids and compositions for intracellular delivery of biologically active compounds
15. 8470799 - Compositions and methods for inhibiting expression of the HAMP gene